Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Seribantumab (Synonyms: SAR-256212, SAR256212, MM-121, MM121)

Catalog No. T76791 Copy Product Info
🥰Excellent
Seribantumab (MM 121) is a humanized monoclonal antibody targeting HER3, inhibiting NRG1-induced growth in MCF-7 cells and patient-derived breast and lung cancer cells harboring NRG1 fusions or amplifications. It also induces apoptosis in MDA-MB-175-VII and LUAD-0061AS3 cells.

Seribantumab

Copy Product Info
🥰Excellent
Catalog No. T76791
Synonyms SAR-256212, SAR256212, MM-121, MM121

Seribantumab (MM 121) is a humanized monoclonal antibody targeting HER3, inhibiting NRG1-induced growth in MCF-7 cells and patient-derived breast and lung cancer cells harboring NRG1 fusions or amplifications. It also induces apoptosis in MDA-MB-175-VII and LUAD-0061AS3 cells.

Seribantumab
Cas No. 1334296-12-6
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$78In StockIn Stock
5 mg$237In StockIn Stock
10 mg$383-In Stock
25 mg$629-In Stock
50 mg$889-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:96.26% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Seribantumab (MM 121) is a humanized monoclonal antibody targeting HER3, inhibiting NRG1-induced growth in MCF-7 cells and patient-derived breast and lung cancer cells harboring NRG1 fusions or amplifications. It also induces apoptosis in MDA-MB-175-VII and LUAD-0061AS3 cells.
Targets&IC50
LUAD-0061AS3 cell:1.4 μM, MDA-MB-175-VII cells:0.02 μM, HBECp53 cell:203 μM, MCF-7 cells:45.2 μM
In vitro
Methods: seribantumab (0.1, 1, 10 μM) was used to treat cancer cells.
Results: seribantumab inhibited neuregulin (NRG1) fusion dependent tumorigenosis.
The IC50 values of Seribantumab for MDA-MB-175-VII cells, LUAD-0061AS3 cells, MCF-7 cells, and HBECp53 cells were 0.02 μM, 1.4 μM, 45.2 μM, and 203 μM, respectively. [1]
In vivo
Seribantumab (0.6 mg, 0.75 mg, or 1 mg per dose twice weekly) was injected into mice with LUAD-0061AS3 PDX tumors, and results showed that seribantumab was more effective than afatinib in reducing tumor growth. [1]
SynonymsSAR-256212, SAR256212, MM-121, MM121
Reactivity
Human
Verified Activity
Immobilized Human HER3 Protein (His) at 2 μg/mL (30 μL/well) can bind Seribantumab. The EC50 is 0.01214 μg/mL.
verifiedActivity
Application
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetERBB3/HER3
Chemical Properties
Molecular Weight143.14 kDa
Cas No.1334296-12-6
Antibody Information
IsotypeHuman IgG2 lambda
Recommended Isotype Control
Storage & Solubility Information
Storage-20°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Citations

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Seribantumab | purchase Seribantumab | Seribantumab cost | order Seribantumab | Seribantumab in vivo | Seribantumab in vitro | Seribantumab molecular weight